NICE'S donepezil,galantamine and rivastigmine view stands

The Pharmaceutical Journal Group

首页> 外文期刊>The pharmaceutical journal >NICE'S donepezil,galantamine and rivastigmine view stands

【24h】

NICE'S donepezil,galantamine and rivastigmine view stands

机译：NICE的多奈哌齐，加兰他敏和rivastigmine观景台

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The National Institute for Health and Clinical Excellence's draft recommendation that donepezil,galantamine and rivastigmine should only be used for patients with moderately severe Alzheimer's disease will remain unchanged when its appraisal of Alzheimer's medicines is published next month.

机译：美国国家卫生与临床卓越研究所的建议草案建议，多奈哌齐，加兰他敏和卡巴拉汀只能用于中度重度阿尔茨海默氏病患者，下个月将发布对阿尔茨海默氏病的评估。

著录项

来源
《The pharmaceutical journal》 |2006年第7422期|共1页
作者
The Pharmaceutical Journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. NICE'S donepezil,galantamine and rivastigmine view stands [J] . The Pharmaceutical Journal Group The pharmaceutical journal . 2006,第7422期

机译：NICE的多奈哌齐，加兰他敏和rivastigmine观景台
2. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of TA111): a systematic review and economic model [J] . Health technology assessment: HTA . 2012,第21期

机译：多奈哌齐，加兰他敏，卡巴拉汀和美金刚治疗阿尔茨海默氏病的有效性和成本效益（TA111综述）：系统评价和经济模型
3. Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis [J] . Tan Chen-Chen, Yu Jin-Tai, Wang Hui-Fu, Journal of Alzheimer's disease: JAD . 2014,第2期

机译：多奈哌齐，加兰他敏，利伐斯的明和美金刚治疗阿尔茨海默氏病的疗效和安全性：系统评价和荟萃分析
4. REMOTE VIEWING NO LONGER A NICE TO DO [C] . Ken Barat International laser safety conference : Conference program amp; proceedings . 2011

机译：远程查看不再需要做
5. French Views of Venice: From the Fourth Crusade through Napoleon. [D] . Griffith, Elizabeth Anna. 2013

机译：法国对威尼斯的看法：从第四次十字军东征到拿破仑。
6. The effectiveness and cost-effectiveness of donepezil galantamine rivastigmine and memantine for the treatment of Alzheimers disease (review of Technology Appraisal No. 111): a systematic review and economic model. [O] . M Bond, G Rogers, J Peters, -1

机译：阿尔茨海默氏病的治疗的有效性和多奈哌齐加兰他敏卡巴拉汀的成本效益及美金刚（估价111号审查技术）的系统评价和经济模式。
7. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. [O] . Bond, M, Rogers, G, Peters, J, 2013

机译：多奈哌齐，加兰他敏，卡巴拉汀和美金刚治疗阿尔茨海默氏病的有效性和成本效益（技术鉴定报告编号111）：系统评价和经济模型。

NICE'S donepezil,galantamine and rivastigmine view stands

摘要

著录项

相似文献

相关主题

期刊订阅